The OFTT can help patients identify insulin sensitivity impairments, insulin resistance, beta-cell dysfunctions and secretion disorders of gut hormones, including glucose-dependent insulinotropic polypeptides and glucagon-like peptide-1 (21, 50). The gene discussed is GCG; the disease is Insulin resistance.